Jonathan Symonds

Jonathan Richard Symonds is the founder of Felix Pharmaceuticals Pvt Ltd. (2015).
Mr. Symonds is also the founder of Oxford University Centre for Business Taxation.
Current jobs include Non-Executive Chairman at GSK Plc (2019), Non-Executive Director at Genomics England Ltd. (2014), Member of the Governors Board at Harrow School, Member of The Institute of Chartered Accountants in England & Wales, and Member of the European Round Table For Industry.
Former jobs include Deputy Group Chairman at HSBC Holdings Plc (2014-2020), Chairman at HSBC Bank Plc (2014-2018), Chairman at Innocoll, Inc., Chairman of the Supervisory Board at Innocoll AG, Chairman at The 100 Group, Chairman of the Supervisory Board at Innocoll Biotherapeutics Holdings Ltd. (2014-2017), Non-Executive Director at Diageo Plc (2004-2007), Managing Director at The Goldman Sachs Group, Inc. (2007-2009), Independent Director at Proteus Digital Health, Inc. (2014-2015), Non-Executive Director at QinetiQ Group plc, Director of Finance at Zeneca Group Plc, Director at Accounting Standards Board, Independent Non-Executive Director at Rubius Therapeutics, Inc. (2018-2023), Director at Berg LLC (2016-2017), Chief Financial Officer at AstraZeneca PLC (1997-2007), Chief Financial Officer at Novartis AG (2009-2014), Partner at KPMG LLP (Canada) (1992-1997), and Head of Corporate Finance & Strategy at Mesoblast Ltd. Education includes an undergraduate degree from the University of Hertfordshire (1980).